Goa-based Molbio Diagnostics has received approval from the Drug Controller General of India (DCGI) for its Truenat Scrub T test for Scrub Typhus, an infectious disease that can spread to humans through the bite of an infected chigger (larval mites).
Scrub Typhus affects approximately one million people in India every year. As per the PLOS report July 2021, the highest densities of cases were from Tamil Nadu (37.6% of cases), Himachal Pradesh (11%), Karnataka (8.8%), and Uttrakhand (8.5%).
Real-Time PCR is the most accurate and sensitive method of diagnosis of infection with Scrub Typhus. With Truenat testing at point of care, the disease can be detected at an early stage efficiently and can be controlled effectively.
“Truenat is a platform that has the approval to test 30+ diseases, the latest being Scrub Typhus. The single platform, Truenat, can test for all diseases with just a different chip. This is the perfect solution for quality healthcare,” Dr Chandrasekhar Nair, Director & CTO, Molbio Diagnostics added.
